• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低疾病活动度(DAS28≤3.2)可降低类风湿关节炎患者首发心血管事件风险:一项大型队列研究中的时间依赖性 Cox 回归分析。

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.

机构信息

Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Department of Rheumatology, Medicines Evaluation Board, Utrecht, The Netherlands.

出版信息

Ann Rheum Dis. 2017 Oct;76(10):1693-1699. doi: 10.1136/annrheumdis-2016-210997. Epub 2017 Jun 12.

DOI:10.1136/annrheumdis-2016-210997
PMID:28606965
Abstract

OBJECTIVE

Systemic inflammation appears to contribute to the excess risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA). The objective of this study was to investigate the effect of different levels of disease activity over time, particularly low disease activity and remission, on CVD risk in patients with RA.

METHODS

Data from the Nijmegen early RA inception cohort were used. The primary outcome was first CVD events within the first 10 years of follow-up. Cut points of the DAS28 for remission (<2.6) and low (≤3.2), moderate (3.2-5.1) and high (>5.1) disease activity were used. The effect of disease activity on CVD risk was analysed using Cox-proportional hazards regression with DAS28 as a time-dependent covariate and also conventionally with time-averaged DAS28 as the primary dependent variable.

RESULTS

Low DAS28 (≤3.2) was significantly associated with a reduced risk of CVD (HR 0.65, 95% CI 0.43 to 0.99) compared with DAS28 >3.2, both when included as a time-dependent covariate and as time-averaged DAS28 ≤3.2 (HR 0.52, 95% CI 0.33 to 0.81). Remission had a modest, non-significant protective effect against CVD (HR 0.67, 95% CI 0.43 to 1.07).

CONCLUSION

Results of this study suggest that low disease activity is sufficient to achieve a protective effect against CVD in RA. Apparently, remission defined as DAS28 <2.6 has no additional protective effect against CVD compared with low disease activity. Our results strengthen the use of tight control strategies in daily clinical practice to achieve low stable disease activity or remission in patients with RA as soon as possible.

摘要

目的

全身性炎症似乎导致类风湿关节炎(RA)患者的心血管疾病(CVD)风险增加。本研究旨在探讨疾病活动度随时间的变化,尤其是低疾病活动度和缓解,对 RA 患者 CVD 风险的影响。

方法

使用尼美根早期 RA 发病队列的数据。主要结局是在随访的前 10 年内首次发生 CVD 事件。采用 DAS28 的缓解(<2.6)和低(≤3.2)、中(3.2-5.1)和高(>5.1)疾病活动度切点。使用 Cox 比例风险回归分析 DAS28 作为时间依赖性协变量和传统的时间平均 DAS28 作为主要因变量对 CVD 风险的影响。

结果

与 DAS28 >3.2 相比,低 DAS28(≤3.2)与 CVD 风险降低显著相关(HR 0.65,95%CI 0.43-0.99),包括作为时间依赖性协变量和时间平均 DAS28 ≤3.2(HR 0.52,95%CI 0.33-0.81)。缓解对 CVD 有适度但无统计学意义的保护作用(HR 0.67,95%CI 0.43-1.07)。

结论

本研究结果表明,低疾病活动度足以对 RA 患者的 CVD 产生保护作用。显然,与低疾病活动度相比,DAS28 <2.6 定义的缓解对 CVD 没有额外的保护作用。我们的研究结果加强了在日常临床实践中使用严格控制策略,使 RA 患者尽快达到低且稳定的疾病活动度或缓解的重要性。

相似文献

1
Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.低疾病活动度(DAS28≤3.2)可降低类风湿关节炎患者首发心血管事件风险:一项大型队列研究中的时间依赖性 Cox 回归分析。
Ann Rheum Dis. 2017 Oct;76(10):1693-1699. doi: 10.1136/annrheumdis-2016-210997. Epub 2017 Jun 12.
2
The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.疾病持续时间和疾病活动度对类风湿关节炎患者心血管疾病风险的影响。
Ann Rheum Dis. 2015 Jun;74(6):998-1003. doi: 10.1136/annrheumdis-2013-204531. Epub 2014 Jan 23.
3
Time-averaged DAS28 and HAQ predict cardiovascular disease in patients with rheumatoid arthritis: Data from KORONA registry.时间平均DAS28和HAQ可预测类风湿关节炎患者的心血管疾病:来自KORONA注册研究的数据。
Joint Bone Spine. 2022 Oct;89(5):105401. doi: 10.1016/j.jbspin.2022.105401. Epub 2022 May 2.
4
The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.类风湿关节炎(RA)病情复发及RA严重程度的累积负担在心血管疾病风险中的作用。
Ann Rheum Dis. 2016 Mar;75(3):560-5. doi: 10.1136/annrheumdis-2014-206411. Epub 2015 Jan 30.
5
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.探讨疾病活动度变化作为甲氨蝶呤治疗类风湿关节炎降低心血管风险的中介因素。
Ann Rheum Dis. 2021 Nov;80(11):1385-1392. doi: 10.1136/annrheumdis-2021-220125. Epub 2021 May 28.
6
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.四种现行风险算法在预测早期类风湿关节炎患者心血管事件中的表现。
Ann Rheum Dis. 2015 Apr;74(4):668-74. doi: 10.1136/annrheumdis-2013-204024. Epub 2014 Jan 3.
7
Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.类风湿关节炎患者使用羟氯喹与心血管事件发生率降低相关。
J Am Heart Assoc. 2016 Jan 4;5(1):e002867. doi: 10.1161/JAHA.115.002867.
8
Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.类风湿关节炎疾病活动度预测新发病的临床明显类风湿关节炎相关间质性肺病:一项前瞻性队列研究。
Arthritis Rheumatol. 2019 Sep;71(9):1472-1482. doi: 10.1002/art.40904. Epub 2019 Aug 4.
9
Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.类风湿关节炎心血管风险预测:原始和改编 SCORE 算法的性能。
Ann Rheum Dis. 2016 Apr;75(4):674-80. doi: 10.1136/annrheumdis-2014-206879. Epub 2015 Feb 17.
10
Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.早期类风湿关节炎中抗磷酸胆碱自身抗体水平较高,表明发生心血管事件的风险较低。
Arthritis Res Ther. 2021 Jul 27;23(1):201. doi: 10.1186/s13075-021-02581-0.

引用本文的文献

1
Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis-A Narrative Review.脂蛋白的翻译后修饰:类风湿关节炎中连接炎症与心血管疾病的新兴因素——一篇叙述性综述
Int J Mol Sci. 2025 Sep 2;26(17):8514. doi: 10.3390/ijms26178514.
2
A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis.一项纵向队列研究发现了早于类风湿性关节炎临床发病和治疗反应的血浆蛋白生物标志物。
Nat Commun. 2025 Jul 21;16(1):6692. doi: 10.1038/s41467-025-62032-1.
3
Management of Late-Onset Rheumatoid Arthritis with Treat-to-Target Strategy.
采用达标治疗策略管理晚发型类风湿关节炎
Drugs Aging. 2025 May;42(5):413-433. doi: 10.1007/s40266-025-01195-4. Epub 2025 Apr 9.
4
The Frequency of Cardiovascular Diseases in Rheumatoid Arthritis in Brazil: 10-year Cohort Study with DATASUS Databases.巴西类风湿关节炎患者心血管疾病的发病率:基于DATASUS数据库的10年队列研究
Arq Bras Cardiol. 2025 Mar 21;122(2):e20240313. doi: 10.36660/abc.20240313. eCollection 2025.
5
Correlation between myocardial work and disease activity in rheumatoid arthritis patients with preserved left ventricular ejection fraction: a retrospective study based on non-invasive pressure-strain loop:.左心室射血分数保留的类风湿关节炎患者心肌工作与疾病活动的相关性:基于无创压力-应变环的回顾性研究
Clin Rheumatol. 2025 Apr;44(4):1513-1525. doi: 10.1007/s10067-025-07380-5. Epub 2025 Mar 5.
6
Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study.类风湿关节炎患者的脑血管风险:来自帕拉塞尔苏斯一万研究中颈动脉粥样硬化的见解。
Rheumatol Int. 2025 Jan 18;45(2):33. doi: 10.1007/s00296-024-05781-4.
7
Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins.四种生物疗法在类风湿关节炎中的疾病反应与对氧磷酶-1 活性和氧化脂质的改善相关。
RMD Open. 2024 Oct 26;10(4):e004829. doi: 10.1136/rmdopen-2024-004829.
8
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases.风湿免疫性炎症性疾病中心血管受累的当前认识和管理。
Nat Rev Rheumatol. 2024 Oct;20(10):614-634. doi: 10.1038/s41584-024-01149-x. Epub 2024 Sep 2.
9
Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients.类风湿关节炎患者代谢综合征的患病率及相关因素。
BMC Endocr Disord. 2024 Aug 5;24(1):140. doi: 10.1186/s12902-024-01675-5.
10
Low-Dose Glucocorticoids in Older Patients with Rheumatoid Arthritis: What Does the Evidence Say?老年类风湿关节炎患者应用小剂量糖皮质激素:证据说了什么?
Drugs Aging. 2024 Aug;41(8):641-652. doi: 10.1007/s40266-024-01133-w. Epub 2024 Jul 27.